- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New products help Lumisys results
A series of new products launched in 1996 helped film digitizermanufacturer Lumisys post record sales for the year (end-December).For the year, the Sunnyvale, CA, company reported sales of $23million, up 30% compared with $17.7 million the year before.
A series of new products launched in 1996 helped film digitizermanufacturer Lumisys post record sales for the year (end-December).For the year, the Sunnyvale, CA, company reported sales of $23million, up 30% compared with $17.7 million the year before. Netincome for 1996 stood at $3.4 million, compared with $2.6 millionin 1995.
Among the highlights for Lumisys in 1996 were the launches ofseveral new film digitizers, as well as the acquisition of QuickSilverSystems and its Quick Read 2000 ultrasound workstation, whichis expected to launch in the first half of this year. Lumisysalso reported that it completed a management restructuring atits Imagraph subsidiary.
In another personnel move, Lumisys hired former Toshiba and GEexecutive Kuldip Ahluwalia as vice president of marketing andnew business development.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
